RLAY
Relay Therapeutics Inc
NASDAQ: RLAY · HEALTHCARE · BIOTECHNOLOGY
$12.57
-3.53% today
Updated 2026-04-29
Market cap
$2.41B
P/E ratio
—
P/S ratio
156.64x
EPS (TTM)
$-1.61
Dividend yield
—
52W range
$3 – $17
Volume
3.0M
Relay Therapeutics Inc (RLAY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $82.65M | $3.03M | $1.38M | $25.55M | $10.01M | $15.36M |
| Revenue growth (YoY) | — | — | — | -96.3% | -54.4% | +1749.8% | -60.8% | +53.4% |
| Cost of revenue | $2.15M | $2.85M | $3.55M | $3.92M | $4.13M | $5.27M | $5.46M | $3.56M |
| Gross profit | $-2.15M | $-2.85M | $79.11M | $3.03M | $1.38M | $25.55M | $10.01M | $11.80M |
| Gross margin | — | — | 95.7% | 100.0% | 100.0% | 100.0% | 100.0% | 76.8% |
| R&D | $41.03M | $70.31M | $99.86M | $172.65M | $246.35M | $330.02M | $319.09M | $261.38M |
| SG&A | $8.86M | $13.74M | $38.59M | $57.39M | $65.98M | $74.95M | $76.59M | $56.71M |
| Operating income | $-49.89M | $-84.05M | $-55.80M | $-364.70M | $-299.27M | $-373.00M | $-372.47M | $-302.74M |
| Operating margin | — | — | -67.5% | -12040.2% | -21670.9% | -1460.1% | -3722.1% | -1971.6% |
| EBITDA | $-47.73M | $-81.20M | $-52.25M | $-223.08M | $-306.82M | $-374.15M | $-380.21M | $-272.92M |
| EBITDA margin | — | — | -63.2% | -7364.9% | -22217.4% | -1464.6% | -3799.4% | -1777.4% |
| EBIT | $-49.89M | $-84.05M | $-55.80M | $-227.01M | $-310.95M | $-379.42M | $-385.67M | $-276.48M |
| Interest expense | $0.00 | $0.00 | $0.00 | $826000.00 | $8.77M | — | — | — |
| Income tax | $1.10M | $-8.80M | $-3.40M | $132.94M | $-36.25M | $-37.47M | $-337.71M | — |
| Effective tax rate | -2.3% | 11.7% | 6.1% | -57.6% | 11.1% | 9.9% | 50.0% | 0.0% |
| Net income | $-48.78M | $-66.50M | $-52.41M | $-363.87M | $-290.51M | $-341.97M | $-337.71M | $-276.48M |
| Net income growth (YoY) | — | -36.3% | +21.2% | -594.3% | +20.2% | -17.7% | +1.2% | +18.1% |
| Profit margin | — | — | -63.4% | -12012.9% | -21036.1% | -1338.7% | -3374.7% | -1800.6% |